Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Clinical Trials

Two major studies strengthen case for prostate cancer drug before chemotherapy

Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.

The results, published in Lancet Oncology, showed that men with advanced, aggressive prostate cancer lived more than four months longer on average if they… Two major studies strengthen case for prostate cancer drug before chemotherapy   

recurrent infection2 - yeshiva university1 - munchausen syndrome1 - kidney research1 - laparoscopic operations1 - bladder stones1 - treatment of prostate cancer1 - crescenteric glomerulonephritis1 - kit kat1 - fetal bladder1 - obstructive lower urinary tract symptoms1 - microhematuria1 - bartholin gland1 - mortality rates1 - renal carcinoma1 - zetia1 - dehydration1 - sexual abuse1 - congenital malformations of urinary tract1 - transplant renal artery stenosis1 - bladder injury1 - the american society of nephrology3 - thrombotic thrombocytopenic purpura1 - androgen receptor1 - prostate cancer test1 - incontinence severity2 - pelvic circulation1 - urinary reflux1 - psa velocity screening1 - resistant to hormone depletion1 -